Audrone Eidukaite
Audrone Eidukaite has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Vytas Tamosiunas
4 shared publicationsAlmantas Siaurys
Department of Molecular Immunology, Institute of Immunology, Vilnius, Lithuania
1 shared publication
Latest Publications
- 1 February 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 89 (2) , 465-467
Soluble HLA-G in the peritoneal fluid of women with endometriosis
- 1 February 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 89 (2) , 465-467
Soluble HLA-G in the peritoneal fluid of women with endometriosis
- 8 March 2006
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 55 (4) , 276-281
Aberrant Expression of CD95 and CD69 Molecules among CD56+ Cells in Women with Endometriosis
Problem Activated lymphocytes can be eliminated by Fas/Fas ligand (FasL)‐induced cell death. Endometrial cells express FasL. The aim of our study was to determine the expression of CD56+ cells (natural killer and natural killer T cells) Fas antigen CD95 and the early activation molecule CD69 in the peritoneal fluid of women with endometriosis.Method Two‐colour flow cytometry was used.Results In the early stages of endometriosis, more CD56+ cells expressed CD69 and CD95 molecules when compared with the control group. However, in case of severe endometriosis the percentage of CD95+CD56+ cells in peritoneal fluid was similar to that of the control group, but the expression of CD69 molecules remained high.Conclusion Because of Fas/FasL mechanisms, in the initial stages of endometriosis the activated peritoneal fluid CD56+ cells can be intensively eliminated, thus providing conditions for the survival of ectopic endometrial cells and the development of the disease.
- 8 March 2006
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 55 (4) , 276-281
Aberrant Expression of CD95 and CD69 Molecules among CD56+ Cells in Women with Endometriosis
Problem Activated lymphocytes can be eliminated by Fas/Fas ligand (FasL)‐induced cell death. Endometrial cells express FasL. The aim of our study was to determine the expression of CD56+ cells (natural killer and natural killer T cells) Fas antigen CD95 and the early activation molecule CD69 in the peritoneal fluid of women with endometriosis.Method Two‐colour flow cytometry was used.Results In the early stages of endometriosis, more CD56+ cells expressed CD69 and CD95 molecules when compared with the control group. However, in case of severe endometriosis the percentage of CD95+CD56+ cells in peritoneal fluid was similar to that of the control group, but the expression of CD69 molecules remained high.Conclusion Because of Fas/FasL mechanisms, in the initial stages of endometriosis the activated peritoneal fluid CD56+ cells can be intensively eliminated, thus providing conditions for the survival of ectopic endometrial cells and the development of the disease.
- 26 July 2004
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 52 (2) , 113-117
Endometrial and Peritoneal Macrophages: Expression of Activation and Adhesion Molecules
Macrophages are highly individualized in tissues and their activities are a reflection of systemic and local environmental signals. The expression of activation (CD69, CD71) and adhesion (CD54) molecules on the surface of CD14+ endometrial macrophages at various phases of the menstrual cycle was compared with the cell surface receptors of peritoneal fluid macrophages. Two-colour-flow cytometry was used to determine the peritoneal and endometrial macrophage phenotype. Endometrium macrophages expressed a lower level of CD69+ and CD54+ macrophages than peritoneal macrophages. However, CD71 receptors displayed similar expression in both macrophage populations, endometrium and peritoneal, except during the proliferative phase. These findings demonstrate the differences between macrophages from endometrium and peritoneal fluid with regard to CD69, CD71 and CD54 expression. In addition, increased numbers of endometrial macrophages in the late secretory phase of the menstrual cycle suggest that they may play a role in menstruation.
- 26 July 2004
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 52 (2) , 113-117
Endometrial and Peritoneal Macrophages: Expression of Activation and Adhesion Molecules
Macrophages are highly individualized in tissues and their activities are a reflection of systemic and local environmental signals. The expression of activation (CD69, CD71) and adhesion (CD54) molecules on the surface of CD14+ endometrial macrophages at various phases of the menstrual cycle was compared with the cell surface receptors of peritoneal fluid macrophages. Two-colour-flow cytometry was used to determine the peritoneal and endometrial macrophage phenotype. Endometrium macrophages expressed a lower level of CD69+ and CD54+ macrophages than peritoneal macrophages. However, CD71 receptors displayed similar expression in both macrophage populations, endometrium and peritoneal, except during the proliferative phase. These findings demonstrate the differences between macrophages from endometrium and peritoneal fluid with regard to CD69, CD71 and CD54 expression. In addition, increased numbers of endometrial macrophages in the late secretory phase of the menstrual cycle suggest that they may play a role in menstruation.
- 7 January 2004
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 42 (6) , 590-4
Activity of eosinophils and immunoglobulin E concentration in the peritoneal fluid of women with endometriosis
Autoinflammatory phenomena, including autoantibody production and atopy, have been regarded as associated with endometriosis. The present study investigates the activity of eosinophils and the distribution of immunoglobulin E concentrations in the peritoneal fluid of women with early endometriosis. The study group consisted of 30 patients with laparoscopically diagnosed early endometriosis. The healthy control group consisted of 18 females with no evident changes in the abdominal cavity and no endometrial foci. Concentrations of immunoglobulin E in serum and peritoneal blood were determined by enzyme immunoassay. The activity of eosinophils was estimated according to the expression of the early activation molecule CD69 by the flow cytometry method. The concentrations of immunoglobulin E in the peripheral blood and peritoneal fluid were similar in both groups. However, the count of CD69+ eosinophils was higher in the peritoneal fluid of women with endometriosis. The results indicate that activated eosinophils accumulate in the peritoneal fluid in early endometriosis and can play a significant role in the pathogenesis of the disease.
- 7 January 2004
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 42 (6) , 590-4
Activity of eosinophils and immunoglobulin E concentration in the peritoneal fluid of women with endometriosis
Autoinflammatory phenomena, including autoantibody production and atopy, have been regarded as associated with endometriosis. The present study investigates the activity of eosinophils and the distribution of immunoglobulin E concentrations in the peritoneal fluid of women with early endometriosis. The study group consisted of 30 patients with laparoscopically diagnosed early endometriosis. The healthy control group consisted of 18 females with no evident changes in the abdominal cavity and no endometrial foci. Concentrations of immunoglobulin E in serum and peritoneal blood were determined by enzyme immunoassay. The activity of eosinophils was estimated according to the expression of the early activation molecule CD69 by the flow cytometry method. The concentrations of immunoglobulin E in the peripheral blood and peritoneal fluid were similar in both groups. However, the count of CD69+ eosinophils was higher in the peritoneal fluid of women with endometriosis. The results indicate that activated eosinophils accumulate in the peritoneal fluid in early endometriosis and can play a significant role in the pathogenesis of the disease.